Cipla
Sumithra Suresh currently serves as the Head Legal for Global M&A at Cipla since October 2022. Prior to this role, Sumithra worked at L&L Partners from August 2012 to October 2022, holding various positions including Partner, Managing Associate, Senior Associate, and Associate, focusing on Mergers & Acquisitions and Anti-Corruption. Additional experience includes serving as Joint Leader of the All India Training Vertical at IDIA from July 2011 to October 2012, and completing internships at firms such as Trilegal, Luthra & Luthra Law Offices, AZB & Partners, and the Competition Commission of India. Sumithra holds a Bachelor of Laws (LL.B.) from Nalsar University of Law, Hyderabad, graduating in 2012, and has a background in studies from Bharatiya Vidya Bhavan, Chennai.
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.